SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
The Pharmaceutical Industry and the Revolution in Molecular Biology: Interactions Among Scientific, Institutional, and Organizational Change
0 references·16 citing·51 second hopsampled
The Pharmaceutical Industry and the Revolution in Molecular Biology: Interactions Among Scientific, Institutional, and Organizational Change (1999)The Pharmaceutical Industry and the Revol…The evolution of the pharmaceutical industry (2015)The evolution of the pharmace…Abductive Reasoning: How Innovators Navigate in the Labyrinth of Complex Product Innovation (2015)Abductive Reasoning: How Inno…Financialization and productive models in the pharmaceutical industry (2013)Financialization and producti…Innovation and Firm Growth: Is R&D Worth It? (2012)Innovation and Firm Growth: I…How venture capital became a component of the US National System of Innovation (2011)How venture capital became a …Organizational and Institutional Genesis: The Emergence of High-Tech Clusters in the Life Sciences (2010)Organizational and Institutio…Entrepreneurship and the construction of value in biotechnology (2010)Entrepreneurship and the cons…Networks and Institutions (2008)Networks and InstitutionsInterdependencies in Complex Project Ecologies: The Case of Biomedical Innovation (2007)Interdependencies in Complex …Rational drug design, the knowledge value chain and bioscience megacentres (2005)Rational drug design, the kno…50th Anniversay Article: The Strategy Field from the Perspective of Management Science : Divergent Strands and Possible Integration (2004)50th Anniversay Article: The …Institutional frameworks and innovation in the German and UK pharmaceutical industry (2003)Institutional frameworks and …Innovation and market structure in the dynamics of the pharmaceutical industry and biotechnology: towards a history-friendly model (2002)Innovation and market structu…Asset accumulation, interdependence and technological change: evidence from pharmaceutical drug discovery (2002)Asset accumulation, interdepe…Alternative societal models of learning and innovation in the knowledge economy (2002)Alternative societal models o…Economies of Scale in Experimentation: Knowledge and Technology in Pharmaceutical R&D (2000)Economies of Scale in Experim…Economic Welfare and the Allocation of Resources for Invention (1962)An Evolutionary Theory of Economic Change. (1983)Profiting from technological innovation: Implications for integration, collaboration, licensing and public policy (1986)Documenting the financialisation of the pharmaceutical industry (2020)Innovation in pharmaceutical R&D: mapping the research landscape (2020)A dynamic multi-sector analysis of technological catch-up: The impact of technology cycle times, knowledge base complexity and variety (2021)The Economic Institutions of Capitalism (1987)The Competitive Advantage of Nations (1990)The Competitive Advantage of Nations (1991)Creating Silicon Valley in Europe (2007)When ‘national innovation system’ meet ‘varieties of capitalism’ arguments on labour qualifications: On the skill types and scientific knowledge needed for radical and incremental product innovations (2011)National institutional differences and cross-border university–industry knowledge transfer (2012)Firm Resources and Sustained Competitive Advantage (1991)Dynamic capabilities and strategic management (1997)Firm resources and sustained competitive advantage (2004)Swift and Smart: The Moderating Effects of Technological Capabilities on the Market Pioneering–Firm Survival Relationship (2009)Invited Editorial: Building a Bridge Between Resource Acquisition and Resource Accumulation (2010)The impact of global and local cohesion on innovation in the pharmaceutical industry (2011)Profiting from technological innovation: Implications for integration, collaboration, licensing and public policy (1993)Measuring Competence? Exploring Firm Effects in Pharmaceutical Research (1994)Scale, Scope, and Spillovers: The Determinants of Research Productivity in Drug Discovery (1996)Innovation and the dynamics and evolution of industries: Progress and challenges (2006)Economic Action and Social Structure: The Problem of Embeddedness (1985)A Dynamic Theory of Organizational Knowledge Creation (1994)How do cities approach policy innovation and policy learning? A study of 30 policies in Northern Europe and North America (2010)A Design Theory for Digital Platforms Supporting Online Communities: A Multiple Case Study (2015)Knowledge worker mobility and knowledge management in MNEs: A bibliometric analysis and research agenda (2022)The Iron Cage Revisited: Institutional Isomorphism and Collective Rationality in Organizational Fields (1983)Absorptive Capacity: A New Perspective on Learning and Innovation (1990)Co-evolution of demand and supply under competition (2009)What evolves in organizational co-evolution? (2015)Organizational and Perceived Learning in the Workplace: A Multilevel Perspective on Employees’ Problem Solving (2019)An Evolutionary Theory of Economic Change (1983)Innovation and Learning: The Two Faces of R & D (1989)The Role of Human Capital in Lowering the Barriers to Engaging in Innovation: Evidence from the Spanish Innovation Survey (2014)Persistence of innovation and patterns of firm growth (2019)The impact of high-speed rail on innovation: An empirical test of the companion innovation hypothesis of transportation improvement with China’s manufacturing firms (2019)Qualitative Analysis for Social Scientists (1987)Basics of Qualitative Research (1992)The Theory of the Growth of the Firm (1995)Managing Innovation Paradox in the Sustainable Innovation Ecosystem: A Case Study of Ambidextrous Capability in a Focal Firm (2017)Dignity Inherent and Earned: The Experience of Dignity at Work (2022)He’s Overqualified, She’s Highly Committed: Qualification Signals and Gendered Assumptions About Job Candidate Commitment (2022)The Strength of Weak Ties (1973)Bowling alone: the collapse and revival of American community (2000)SME internationalization modes in the German biotechnology industry: The influence of imitation, network position, and international experience (2015)Why do policies change? Institutions, interests, ideas and networks in three cases of policy reform (2016)Internationalization barriers of SMEs from developing countries: a review and research agenda (2020)Project Teams as Means of Restructuring Research and Development in the Pharmaceutical Industry (2002)The evolution of knowledge: beyond the biological model (2002)A Capabilities Perspective on the Evolution of Firm Boundaries: A Comparative Case Example from the Portuguese Moulds Industry* (2004)
this work references cited by second hop· second hop is a sample of the most-cited connections

References

No references inside the corpus for this window.

Cited by

  • 2002Innovation and market structure in the dynamics of the pharmaceutical industry and biotechnology: towards a history-friendly model265 cited
  • 2008Networks and Institutions244 cited
  • 2002Asset accumulation, interdependence and technological change: evidence from pharmaceutical drug discovery183 cited
  • 2015The evolution of the pharmaceutical industry177 cited
  • 2012Innovation and Firm Growth: Is R&D Worth It?165 cited
  • 2003Institutional frameworks and innovation in the German and UK pharmaceutical industry156 cited
  • 200450th Anniversay Article: The Strategy Field from the Perspective of Management Science : Divergent Strands and Possible Integration135 cited
  • 2000Economies of Scale in Experimentation: Knowledge and Technology in Pharmaceutical R&D120 cited
  • 2002Alternative societal models of learning and innovation in the knowledge economy109 cited
  • 2015Abductive Reasoning: How Innovators Navigate in the Labyrinth of Complex Product Innovation108 cited
  • 2013Financialization and productive models in the pharmaceutical industry102 cited
  • 2005Rational drug design, the knowledge value chain and bioscience megacentres100 cited
  • 2011How venture capital became a component of the US National System of Innovation95 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

2010
Organizational and Institutional Genesis: The Emergence of High-Tech Clusters in the Life Sciences
93 cited
  • 2010Entrepreneurship and the construction of value in biotechnology92 cited
  • 2007Interdependencies in Complex Project Ecologies: The Case of Biomedical Innovation87 cited